Dignity Health kuArizona iri kuparura tsvakiridzo yekutanga kuNorth America umo ongororo yemajini inoshandiswa kuona varume nevakadzi vari panjodzi yekubatwa nechirwere chemoyo zvichienderana nekugadzirwa kweDNA yavo. Kana yakaratidza kuti inoshanda mumakiriniki ekuyedzwa, iyi fomu yekuongorora majini inogona kugamuchirwa pasi rose kudzivirira chirwere chemoyo. Chirwere chemwoyo ndicho cheNo.
Mukati menguva yese yekudzidza, boka re cardiology pa Dignity Health Chandler Regional Medical Center, Mercy Gilbert Medical Center uye St. Joseph's Hospital uye Medical Center ichatora sampuli dzeDNA kubva kune varume nevakadzi vanenge 2,000 vasina nhoroondo inozivikanwa yechirwere chemoyo. Iwo masampula eDNA anozoongororwa kuBaylor College yeMedical's Human Genome Sequencing Center Clinical Lab kuti vaone kana vatori vechikamu vane genetic markers inozivikanwa kukonzera chirwere chemoyo.
"Iri rinofanira kunge riri zana rekupedzisira rechirwere chemoyo," akadaro Robert Roberts, MD, Medical Director weCardiovascular Genomics yeDignity Health muArizona. "Ndine shuviro yekuti kuburikidza nezvakabuda muongororo iyi tichakwanisa kuponesa hupenyu hwakatowanda mune ramangwana nekuita ongororo yemajini yekudzivirira kwekutanga kwechirwere checoronary artery semazuva ese ekukiriniki."
Kana iyo DNA genotyping yapera, boka riri paDignity Health hospitals muArizona richaongorora mageneti emumwe nemumwe wevatori vechikamu kuti vaone kana vane mukana wakaderera, wepakati kana mukuru wekubatira chirwere chemoyo. Zvimwe zvehutano nemararamiro zvichatariswawo pakusarudza njodzi yevatori vechikamu yechirwere chemoyo. Izvi zvinosanganisira hypertension, chirwere cheshuga, high cholesterol uye kuti mubati wacho anosvuta here kana kuti ari kushanda mumuviri, pakati pevamwe.
Vatori vechikamu chidzidzo vakaratidza chido chekuziva mhedzisiro yavo vachaziviswa netsamba. Vanhu vari panjodzi huru yechirwere chemoyo vachave nemukana wekusangana nenyanzvi dzezvemoyo uye vanopihwa mazano ezvekubereka pazvinenge zvichidiwa zvichienderana nezvavanowana uye nzira dzekudzivirira dzakakodzera dzekudzivirira.
Vaya vanokodzera kutora chikamu muchidzidzo ichi varume nevakadzi vari pakati pemakore 40 ne60. Vanofanirawo kunge vasina nhoroondo inozivikanwa yechirwere chemoyo, sezvo chinangwa chekudzidza ndechekuona njodzi yavo yekuberekwa kwechirwere chemwoyo isati yanyatsokura.
ZVOKUBVA MUNYAYA INO:
- Once the DNA genotyping is completed, the team at Dignity Health hospitals in Arizona will evaluate each participant’s genetic markers to determine if they have a low, medium or high chance of developing heart disease.
- They must also have no known history of heart disease, as the goal of the study is to determine their genetic risk for developing heart disease before it actually develops.
- “I am hopeful that through the results of this study we will be able to save even more lives in the future by implementing genetic testing for early prevention of coronary artery disease as routine clinical application.
